Growth Metrics

Merck (MRK) Minority Interest (2016 - 2026)

Merck has reported Minority Interest over the past 18 years, most recently at $53.0 million for Q1 2026.

  • Quarterly Minority Interest fell 18.46% to $53.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $53.0 million through Mar 2026, down 18.46% year-over-year, with the annual reading at $56.0 million for FY2025, 5.08% down from the prior year.
  • Minority Interest was $53.0 million for Q1 2026 at Merck, down from $56.0 million in the prior quarter.
  • Over five years, Minority Interest peaked at $75.0 million in Q2 2022 and troughed at $49.0 million in Q2 2023.
  • The 5-year median for Minority Interest is $60.0 million (2024), against an average of $61.6 million.
  • Year-over-year, Minority Interest crashed 34.67% in 2023 and then soared 34.69% in 2024.
  • A 5-year view of Minority Interest shows it stood at $67.0 million in 2022, then dropped by 19.4% to $54.0 million in 2023, then rose by 9.26% to $59.0 million in 2024, then dropped by 5.08% to $56.0 million in 2025, then dropped by 5.36% to $53.0 million in 2026.
  • Per Business Quant, the three most recent readings for MRK's Minority Interest are $53.0 million (Q1 2026), $56.0 million (Q4 2025), and $57.0 million (Q3 2025).